key: cord-0740297-prbo1z1d
authors: Dangerfield, Tyler L.; Huang, Nathan Z.; Johnson, Kenneth A.
title: Expression and Purification of Tag-Free SARS-CoV-2 RNA-Dependent RNA Polymerase in Escherichia coli
date: 2021-02-04
journal: STAR Protoc
DOI: 10.1016/j.xpro.2021.100357
sha: c90716b4c3feeb6b293a92494590172eae2122c5
doc_id: 740297
cord_uid: prbo1z1d

The RNA-dependent-RNA polymerase (RdRp) from SARS-CoV-2 is an important drug target as it is responsible for viral RNA genome replication. Efficient production of recombinant RdRp is important in screening antivirals to treat COVID-19. Here we present our protocol for expression of tag-free replication complex proteins in E. coli and subsequent purification. Despite the added complexity of multiple purification steps, our methods provide greater activity and yield at lower cost and are faster than baculovirus expression systems.

The RNA-dependent-RNA polymerase (RdRp) from SARS-CoV-2 is an important drug target as it is responsible for viral RNA genome replication. Efficient production of recombinant RdRp is important in screening antivirals to treat COVID-19. Here we present our protocol for expression of tag-free replication complex proteins in E. coli and subsequent purification. Despite the added complexity of multiple purification steps, our methods provide greater activity and yield at lower cost and are faster than baculovirus expression systems.

For complete details on the use and execution of this protocol, please refer to (Dangerfield et al., 2020) .

The SARS CoV-2 RNA dependent RNA polymerase (RdRp) complex is responsible for replication of the viral RNA genome and consists of non-structural proteins (nsp)12, nsp7 and nsp8. The only FDA approved treatment for COVID-19 infections is the nucleoside analog, Remdesivir, highlighting the importance of this enzyme as a target for therapies to combat the viral infection. Many protocols to express tagged RdRp complex proteins in baculovirus-infected insect cells have been published (Gordon et al., 2020; Hillen et al., 2020; Yin et al., 2020) but these methods are slow, expensive, and have a limited yield. Furthermore, tagged proteins can display different activity than their untagged counterparts, and appropriate controls for the effect of the tag are sorely lacking. Here we present our protocol for co-expression of nsp12/7/8 complex and tag-free nsp8 in E. coli and subsequent purification. The procedure yields approximately 7 mg of highly active enzyme per liter of culture that catalyzes RNA polymerization at a rate sufficient to account replication of the 30 kb viral genome in two minutes (Dangerfield et al., 2020) . .

Prepare Electrocompetent E. coli BL21/ pG-Tf2 J o u r n a l P r e -p r o o f In this step, electrocompetent E. coli BL21 / pG-Tf2 are prepared which will be used to co-express the RdRp complex in E. coli with the aid of chaperone proteins from the pG-Tf2 plasmid.

Timing: 3 days 1. Before starting:

a. Autoclave the following items: 2 liters dH 2 O split into 2 flasks, 100 ml of 10% (v/v) glycerol, 4 x 250 ml centrifuge bottles and caps, 1.5 ml microcentrifuge tubes, 250 ml graduated cylinder, 100 ml graduated cylinder, 1 liter LB media in 2.8 liter bafflebottomed flasks. Add chloramphenicol to 20 µg/ml after cooling to 25°C. b. Chill the following items to 4°C: 2 liters autoclaved dH 2 O, 100 ml autoclaved 10 % (v/v) glycerol, 4 x 250 ml autoclaved centrifuge bottles and caps, 1.5 ml autoclaved microcentrifuge tubes, 250 ml autoclaved graduated cylinder, 100 ml autoclaved graduated cylinder 2. Transform BL21 E. coli with the plasmid pG-Tf2 following transformation protocols for the type of competent BL21 E. coli used. Spread the transformation reaction solution onto an LB/Agar plate containing 20 µg/ml chloramphenicol. 3. Incubate the plate for 16 hours at 37°C. 4. Select a single colony from the plate with the previous day's transformation and inoculate a 10 ml starter culture of 2x YT media (defined under Materials and Equipment) with 20 µg/ml chloramphenicol. Grow the culture for 16 hours at 37°C with shaking at 200 RPM. 5. Inoculate 1 liter of LB media (defined under Materials and Equipment) + 20 µg/ml chloramphenicol with the 10 ml starter culture 6. Incubate cells with shaking at 30°C, 250 RPM. Measure the OD 600 periodically (every half hour or so until the OD 600 reaches 0.2, then every 15 minutes). 7. When the OD 600 reaches 0.35-0.4, immediately put the cells on ice and chill the culture for 25 minutes, swirling occasionally to ensure even cooling. Place centrifuge bottles on ice at this time and move the needed rotors to the centrifuge to start cooling to 4°C

Critical: It is important to not let the OD 600 get any higher than 0.4. The OD 600 should be carefully monitored and checked often, especially when it gets above 0.2 as the cells grow exponentially. It usually takes about 3 hours to reach an OD 600 of 0.35 when using a 10 ml starter culture added to 1 liter of medium. It is also very important to keep the cells at 4°C for the remainder of the procedure following growth. The cells and any bottles or solutions that they come in contact with must be pre chilled to 4°C.

8. Spin 1: Split the 1 liter culture into four parts by pouring about 250 ml into ice cold centrifuge bottles. Harvest the cells by centrifugation at 1,000 x g for 20 minutes at 4°C. 9. Decant the supernatant and re suspend each pellet in 200 ml of ice cold dH 2 O by gentle swirling 10. Spin 2: Harvest the cells by centrifugation at 1,000 x g for 20 minutes at 4°C 11. Decant the supernatant and resuspend each pellet in 100 ml of ice cold dH 2 O with gentle swirling. Combine the resuspensions into 2 centrifuge bottles 12. Spin 3: Harvest the cells by centrifugation at 1,000 x g for 20 minutes at 4°C. At this step chill two 50 ml conical tubes on ice 13. Decant the supernatant and resuspend each pellet in 40 ml of ice cold 10% (v/v) glycerol with gentle swirling. Transfer each suspension to a 50 ml conical tube 14. Spin 4: Harvest the cells by centrifugation at 1,000 x g for 20 minutes at 4°C. Carefully aspirate the supernatant with a sterile Pasteur pipette 15. Re-suspend each pellet in 1 ml of ice cold 10% (v/v) glycerol by gently swirling 16. Aliquot 50 µL into sterile and cold 1.5 ml microfuge tubes and snap freeze in liquid nitrogen.

Store aliquots at -80°C.

Hazard note: Dispose of E. coli cultures as recommended by your local biosafety protocols Transform Expression Plasmids into E. coli BL21

In this step, the expression plasmids are transformed into BL21 E. coli by electroporation. Any transformation protocol can be used for the pcI ts,ind+ -(NSP8) plasmid into BL21 E. coli but the protocol presented here is for electrocompetent cells prepared as described above.

Timing: 1 day 17. Chill 0.1 mm electroporation cuvettes on ice for at least 15 minutes 18. Remove one tube of competent E. coli BL21 and one tube of electrocompetent E. coli BL21/pG-Tf2 made in the previous step from the -80°C freezer and place on ice for 10 minutes 19. Add plasmid DNA to appropriate cells a. Pipette 10 ng of pcI ts,ind+ -(NSP8) in a volume less than 5 µL into the tube of E. coli BL21. Perform transformation following the protocol of the manufacturer of the competent cells. b. Pipette at least 100 ng of pQE-(NSP12)-pcI ts,ind+ -(NSP7-NSP8) in a volume less than 5 µL into the tube of electrocompetent E. coli BL21/pG-Tf2. The rest of the protocol is for transformation into the electrocompetent E. coli BL21/pG-Tf2. 20. Transfer the cells/DNA mixture to the chilled electroporation cuvette and gently tap the cuvette on the lab bench to ensure the cells are in the gap in the bottom of the cuvette 21. Wipe off any water or ice that is on the metal parts of the electroporation cuvette with a Kimwipe (paper tissue). Insert the cuvette into the cuvette holder connected to the Gene Pulser and slide into the safety cover. 22. Electroporate at 1.8 kV, 25 µF by holding down the left red button and pressing the right red button until the machine beeps. Immediately release the buttons after you hear the beep 23. Check that the time constant given on the Gene Pulser is greater than 3.8.

a. If the time constant is less than 3.8, try the transformation again or re-make the competent cells. 24. Immediately add 950 µL of sterile SOC media (defined under Materials and Equipment) to the cuvette and pipette up and down to mix 25. Transfer the cells to a 1.5 ml microcentrifuge tube and do outgrowth at 30°C for 1 hour 26. Plate transformations on selective plates a. Plate E. coli BL21/pcI ts,ind+ -(NSP8) on LB plates with 100 µg/ml ampicillin a. Plate E. coli BL21/pG-Tf2/pQE-(NSP12)-pcI ts,ind+ -(NSP7-NSP8) on LB plates with 30 µg/ml kanamycin and 20 µg/ml chloramphenicol 27. Incubate plates at 30°C J o u r n a l P r e -p r o o f b. E. coli BL21/pcI ts,ind+ -(NSP8) will show colonies after 16-24 hours c. E. coli BL21/pG-Tf2/pQE-(NSP12)-pcI ts,ind+ -(NSP7-NSP8) will take longer to see colonies, 24-48 hours. Step-by-Step Method Details Expression of SARS-CoV-2 nsp8 in E. coli

In this step, a 2 liter culture of E. coli harboring the plasmid pcI ts,ind+ -(NSP8) is grown to a high density. Protein expression is then induced by shifting the temperature from 30°C to 42°C for 20 minutes then to 38°C for 3 hours. Finally, the cells are harvested and frozen for later use in protein purification.

1. Inoculate a single colony from the plate containing E. coli BL21/ pcI ts,ind+ (NSP8) into 8 ml of Terrific broth with 100 µg/ml ampicillin. Incubate for 16 hours with shaking at 30°C, 200 RPM. 2. The following morning pellet the cells by centrifugation at 5,000 x g for 10 minutes. 3. Decant the supernatant and resuspend the cells in 6 ml of fresh Terrific Broth with 100 µg/ml ampicillin. 4. Inoculate each of 2 x 1 liter of Terrific Broth with 100 µg/ml ampicillin, split into 2 x 2.8 liter baffle bottomed flasks, with 3 ml of the resuspended culture from Step 3. Incubate the culture at 30°C with shaking at 250 RPM. 5. Measure the OD 600 of the culture every 30 minutes until the OD 600 reaches 2. 6. When the OD 600 reaches 2, remove a "pre-induction" sample by pelleting (10,000 x g, 5 minutes, 20-25°C) a volume of cells equal to 1 ml at an OD 600 of 6. Aspirate the supernatant then store the pellet at -80°C. 7. Induce expression by moving the cultures to an incubator preheated to 42°C for 20 minutes and incubate with shaking at 250 RPM. 8. Move the cultures to an incubator preheated to 38°C and incubate with shaking at 250 RPM for 3 hours. 9. Measure the OD 600 of the cultures. Take a post-induction sample by pelleting a volume of cells equal to 1 ml at an OD 600 of 6. Decant then aspirate the remaining supernatant. Store the pellet at -80°C. 10. Harvest the cells by centrifugation at 6,000 x g for 20 minutes at 4°C Decant the supernatant then transfer the pellet to a pre-weighed 50 ml conical tube with a spatula. 11. Determine the mass of the tube plus pellet then subtract the mass of the empty tube to get the yield of cell pellet. Record the mass on the tube as well as in your notes. Typical yields are 15-20 g of cell pellet per 2 liters of growth media. 12. Store the pellet at -80°C. The pellet is stable for at least one month at -80°C but likely is stable

for longer than we have tested. In this step, E coli harboring the chaperone plasmid pG-Tf2 and the RdRp complex co-expression plasmid pQE-(NSP12)-pcI ts,ind+ -(NSP7-NSP8) are grown to a high density before inducing expression for 16 hours and harvesting the cells by centrifugation.

13. Inoculate a single colony from the plate with E. coli BL21/pG-Tf2/pQE-(NSP12)-pcI ts,ind+ -(NSP7-NSP8) into an 8 ml starter culture of Terrific Broth with 30 µg/ml kanamycin and 20 µg/ml chloramphenicol. Incubate at 30°C with shaking at 200 RPM for 16 hours. 14. The following morning inoculate the starter culture into 1 liter of Terrific Broth with 30 µg/ml kanamycin and 20 µg/ml chloramphenicol in a 2.8 liter baffle bottomed flask and incubate with shaking at 30°C, 250 RPM. 15. Periodically check the OD 600 of the culture. When the OD 600 reaches 2, take a pre-induction sample by harvesting a volume of cells equal to 1 ml at an OD 600 of 6 and storing the pellet at -80°C. 16. Add tetracycline from a 10 µg/ml stock to a final concentration of 10 ng/ml and move the culture to an incubator pre-cooled to 16°C. 17. Incubate with shaking at 16°C, 250 RPM for 20 minutes 18. Add IPTG to 0.5 mM from a 1 M stock solution. Add nalidixic acid to 50 µg/ml from a 25 mg/ml stock.

Critical: Make 25 mg/ml nalidixic acid stock fresh daily by dissolving the powder into 0.3 M NaOH.

19. Express for 16 hours at 16°C with shaking at 250 RPM 20. Measure the OD 600 . Pellet a volume of cells equal to 1 ml at an OD 600 of 6 and store the pellet at -80°C. 21. Harvest the cells by centrifugation at 6,000 x g for 20 minutes at 4°C 22. Decant the supernatant and transfer the pellet to a pre-weighed 50 ml conical tube with a spatula. Determine the mass of the pellet then store at -80°C. 

Timing: 2 days

In this step, the frozen pellet obtained from the bacterial expression of nsp8 is lysed, and nsp8 is purified by a number of chromatography steps. 54. HiTrap Blue-HP Chromatography: Dilute the pooled fractions with Dilution Buffer-1 until the conductivity of the sample is equal to the conductivity of Buffer A-1 55. Load the sample onto a 5 ml HiTrap Blue-HP column, equilibrated in Buffer A-1 at 10 ml/min.

Collect the flow-through in a separate, labeled container, save a sample for SDS-PAGE, and store at 4°C. 56. Wash the column with 10% Buffer B at 5 ml/min until the UV 280 reaches baseline, collecting the eluate in a separate, labeled container. Save a sample for SDS-PAGE and store at 4°C. 57. Elute bound proteins with a 50 ml linear gradient from 10 -80% Buffer B at 5 ml/min, collecting 2 ml fractions 58. Analyze samples from the Blue column by SDS-PAGE as described above. 59. Pool fractions containing nsp8. 60. Concentrate the pooled fractions by ultrafiltration with Amicon Ultra centrifugal concentrators with a 10 kDa molecular weight cutoff (MWCO) at 4°C until the sample volume is less than 1 ml, following the manufacturer's instructions.

Chromatography: Inject the sample onto the Superdex 200 10/300 GL column, equilibrated in 10% Buffer B with the sample loop on the HPLC. 62. Elute proteins with 10% Buffer B-1, collecting 1 ml fractions. 63. Analyze fractions by SDS-PAGE as described above. 64. Pool fractions containing nsp8 65. Concentration / Storage: Determine the concentration of nsp8 by absorbance at 280 nm using the extinction coefficient ε 280 : 19,940 M -1 cm -1 (Dangerfield et al., 2020) . 66. If necessary, concentrate the sample with Amicon Ultra centrifugal concentrators (10 kDa MWCO) following the manufacturer's protocol . We concentrated the protein to 300 µM at this step without precipitation problems, 67. Dialyze the sample into Storage Buffer-1 with 1 kDa MWCO dialysis tubing at 4°C with 2 x 500 ml x 1 hour buffer changes. 68. Remove the sample from the dialysis tubing and determine the concentration of nsp8 by absorbance at 280 nm using the extinction coefficient above. 69. Divide the purified protein into aliquots, flash freeze into liquid nitrogen and store at -80°C until use.

Purification of nsp12/7/8 95. Dialyze the concentrated sample into Storage Buffer-2 with 1 kDa MWCO dialysis tubing at 4°C with two 500 ml buffer changes, one hour of equilibration for each. 96. Remove sample from dialysis tubing, determine the final volume, and measure the concentration by absorbance at 280 nm using the extinction coefficient ε 280 : 181,300 M -1 cm -1 calculated from the amino acid sequence and assuming one nsp12, one nsp7 and two nsp8 polypeptides per complex. 97. Flash freeze aliquots in liquid nitrogen and store at -80°C.

The expected outcomes are shown in Figures 1, 2 , and 3.

Calculating the final yield in mg of each protein preparation based on the volume and molar concentration measured by absorbance:

To determine the yield of each protein preparation in mg, use the following equation:

10 "# For the nsp8 preparation, the molecular weight is 22,000 g/mol and the typical yield is 25 mg per liter of culture. For the nsp12/7/8 complex preparation, the combined molecular weight of the complex (assuming 2 molecules of nsp8 per molecule of nsp7 and nsp12) is 160,000 g/mol and the typical yield is 7 mg per liter of culture.

While our bacterial expression protocol is significantly less time consuming that baculovirus protein expression, our purification protocols require many more steps than traditional purification of tagged proteins. Also even after multiple chromatography steps, there are still some proteolysis products, visible by SDS-PAGE, in the preparations of both enzymes. Both protein preparations are free from contaminating nuclease activity. Single turnover kinetic analysis shows that the enzyme is greater than 60% active. The purification procedures can likely be further optimized to eliminate these contaminating bands.

Problem 1:

No colonies after transforming expression plasmids into E. coli (Before you begin, step 27).

Ensure E. coli cells are kept as cold as possible after the growth phase (Before you begin, steps 7-16) when preparing competent cells. Add more plasmid DNA before electroporation of competent cells (Before you begin, step 19). 

Ensure all buffer is aspirated after removing the soluble fraction sample (Step-by-step method details, step 32). Perform an additional "wash step" before removing insoluble fraction sample (Step-by-step method details, repeat steps 33-35). Load the same volume of each sample when analyzing results by

Problem 3: No/low expression of nsp8 (Step-by-step method details

Ensure ampicillin plates are made fresh as ampicillin is prone to degradation. Preheat incubators to 30°C, 42°C, and 38°C to ensure efficient heat induction (Step-by-step method details

Make LB/Chl./Kan. plates fresh to prevent satellite colonies. Ensure the nalidixic acid stock is made fresh daily

Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Structure of replicating SARS-CoV-2 polymerase

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

Soluble expression of tag free, highly active SARS-CoV-2 polymerase complex in E. coli. • Purification protocol for NSP-7/8/12 RNA polymerase complex is provided. • Protocol for expression and purification of supplemental NSP8 included. • Purified SARS-CoV-2 RNA polymerase complex catalyzes fast processive RNA replication

This work was supported by grants from NIAID (1R01AI110577 to KAJ) and NIH (R01AI110577 to KAJ) and the Welch Foundation (F-1604 to KAJ). 

The authors declare no competing interests.

Brandis, J.W., and Johnson, K.A. (2009). High-cell density shake-flask expression and rapid purification of the large fragment of Thermus aquaticus DNA polymerase I using a new chemically and temperature inducible expression plasmid in Escherichia coli. Protein expression and purification 63, 120-127.

Add more of the appropriate Dilution Buffer steps 47, 54, 75, 82, 88) and check to the conductivity of the sample to ensure it is below the conductivity of the appropriate Buffer A. Re-make FPLC buffers, taking care to add the correct concentration of NaCl.

Requests for further information should be directed to and will be fulfilled by the Lead Contact, Kenneth A. Johnson (kajohnson@utexas.edu).

All materials in this study can be obtained from sources given in the Key Resources Table.

The published article includes all datasets generated or analyzed during this study